Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of KILITCH DRUGS. For more details, see the KILITCH DRUGS quarterly results and KILITCH DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.6 |
No. of shares | m | 16.08 |
1 Week | % | 0.1 |
1 Month | % | -4.6 |
1 Year | % | 102.9 |
52 week H/L | Rs | 469.9/157.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
KILITCH DRUGS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 242 | 217 | 139 | 276 | 218 | |
Low | Rs | 77 | 63 | 78 | 80 | 121 | |
Sales per share (Unadj.) | Rs | 53.7 | 34.6 | 44.2 | 73.3 | 89.6 | |
Earnings per share (Unadj.) | Rs | 2.5 | 0.5 | 2.4 | 4.0 | 5.3 | |
Diluted earnings per share | Rs | 2.4 | 0.5 | 2.3 | 3.9 | 5.2 | |
Cash flow per share (Unadj.) | Rs | 3.8 | 1.8 | 3.7 | 5.6 | 7.6 | |
Dividends per share (Unadj.) | Rs | 0.50 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0.3 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 78.1 | 75.9 | 81.8 | 87.4 | 93.9 | |
Adj. book value per share | Rs | 74.6 | 72.8 | 78.8 | 84.7 | 90.9 | |
Shares outstanding (eoy) | m | 15.36 | 15.43 | 15.49 | 15.58 | 15.58 | |
Price / Sales ratio | x | 3.0 | 4.1 | 2.5 | 2.4 | 1.9 | |
Avg P/E ratio | x | 64.0 | 257.0 | 44.6 | 44.7 | 31.9 | |
P/CF ratio (eoy) | x | 41.7 | 76.2 | 29.2 | 32.0 | 22.4 | |
Price / Book Value ratio | x | 2.0 | 1.8 | 1.3 | 2.0 | 1.8 | |
Dividend payout | % | 20.0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 2,452 | 2,164 | 1,679 | 2,775 | 2,646 | |
Total wages/salary | Rs m | 53 | 57 | 52 | 62 | 117 |
KILITCH DRUGS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 825 | 533 | 685 | 1,142 | 1,396 | |
Other income | Rs m | 53 | 46 | 27 | 29 | 29 | |
Total revenues | Rs m | 878 | 579 | 712 | 1,171 | 1,425 | |
Gross profit | Rs m | 60 | 0 | 53 | 105 | 177 | |
Depreciation | Rs m | 21 | 20 | 20 | 25 | 36 | |
Interest | Rs m | 6 | 9 | 9 | 13 | 51 | |
Profit before tax | Rs m | 86 | 16 | 51 | 96 | 120 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 48 | 8 | 14 | 34 | 37 | |
Profit after tax | Rs m | 38 | 8 | 38 | 62 | 83 | |
Gross profit margin | % | 7.3 | 0 | 7.8 | 9.2 | 12.7 | |
Effective tax rate | % | 55.4 | 47.6 | 26.4 | 35.4 | 31.1 | |
Net profit margin | % | 4.6 | 1.6 | 5.5 | 5.4 | 5.9 |
KILITCH DRUGS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 649 | 558 | 804 | 1,141 | 1,264 | |
Current liabilities | Rs m | 201 | 220 | 733 | 693 | 689 | |
Net working cap to sales | % | 54.3 | 63.4 | 10.3 | 39.2 | 41.2 | |
Current ratio | x | 3.2 | 2.5 | 1.1 | 1.6 | 1.8 | |
Inventory Days | Days | 238 | 361 | 333 | 236 | 163 | |
Debtors Days | Days | 860 | 1,086 | 1,221 | 1,323 | 1,419 | |
Net fixed assets | Rs m | 777 | 861 | 1,215 | 942 | 911 | |
Share capital | Rs m | 154 | 154 | 155 | 156 | 156 | |
"Free" reserves | Rs m | 1,046 | 1,016 | 1,113 | 1,207 | 1,307 | |
Net worth | Rs m | 1,199 | 1,171 | 1,268 | 1,362 | 1,462 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 1,426 | 1,419 | 2,019 | 2,083 | 2,175 | |
Interest coverage | x | 14.3 | 2.7 | 6.8 | 8.2 | 3.4 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.6 | 0.4 | 0.3 | 0.5 | 0.6 | |
Return on assets | % | 3.1 | 1.3 | 2.3 | 3.6 | 6.1 | |
Return on equity | % | 3.2 | 0.7 | 3.0 | 4.6 | 5.7 | |
Return on capital | % | 7.7 | 2.2 | 4.7 | 8.0 | 11.7 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 797 | 391 | 189 | 509 | 602 | |
Fx outflow | Rs m | 69 | 51 | 49 | 58 | 161 | |
Net fx | Rs m | 729 | 340 | 141 | 450 | 441 |
KILITCH DRUGS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 3 | 45 | 457 | 58 | 26 | |
From Investments | Rs m | -140 | -105 | -376 | -153 | 79 | |
From Financial Activity | Rs m | 169 | 9 | 16 | 70 | -7 | |
Net Cashflow | Rs m | 32 | -51 | 97 | -24 | 98 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Mukund P Mehta | COMP SEC: Pushpa Nyoupane | YEAR OF INC: 1992 | BSE CODE: 524500 | FV (Rs): 10 | DIV YIELD (%): - |
Read: KILITCH DRUGS 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare KILITCH DRUGS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.